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 The oral cavity harbors more than 700 microbial species and is one of the most com-
plex ecosystems ever described. While the majority of these microbes are considered com-
mensal, some of them are responsible for oral infectious diseases such as dental caries, peri-
odontitis, halitosis and stomatitis.  The advancement of modern science has greatly furthered 
our understanding of oral microbes and their roles in host health and disease. It has also led to 
the development of new tools for early detection, effective treatment, and prevention of oral 
microbial infections.  This perspective provides a general understanding of oral microbiology, 
and its clinical relationship to oral infectious diseases, with a specific focus on denture-related 
microbial infections. The perspective also discusses the potential for developing innovative 
interventions for managing denture-related disease based on recent advances in our understand-
ing of oral microbiology and denture-associated biofilms.  
KEYWORDS: Stomatitis; Oral microbiota; Candida albicans.
ABBREVIATIONS: SAP: Aspartyl proteinases; PL: Phospholipase; PDT: Photodynamic therapy; 
STAMPs: Specifically Targeted Antimicrobial Peptides.
INTRODUCTION
 The association between microbes and oral diseases had long been suspected. Dr. W. 
D. Miller is generally recognized as the father of modern dental microbial pathogenesis. His 
1890 seminal book titled Microorganisms of the Human Mouth1 makes the first connection 
between bacteria in dental plaque and tooth decay, and remains a foundation of current under-
standing of dental disease.  For a long time, oral microbes had been indiscriminately regarded 
as pathogens. In fact, their removal from the oral cavity has become the main objective of 
dentists. Not until recently, did we realize that like microbes associated with other parts of the 
human body, most of the oral microorganisms are commensal and might have protective role 
in preventing the colonization of pathogens.2,3 More importantly, increasing evidence suggests 
that oral infectious diseases such as dental caries and periodontitis are often the result of the dis-
turbed host homeostasis, and an imbalanced oral microbial ecology often leads to overgrowth 
of otherwise low abundant opportunistic pathogens.4,5
 Recent advances in molecular biological techniques are broadening our understanding 
of bacterial diversity and the societal community interactions which occur between species in 
the oral cavity.6 This has led to tremendous advances in our understanding of oral microbiology 
and its involvement in health and disease, including tooth decay, gum diseases, as well as the 
diseases associated with artificial dental apparatus introduced through modern dentistry.6,7






ADVANCING UNDERSTANDING OF ORAL MICROBIOLOGY 
THROUGH MOLECULAR BIOLOGICAL APPROACHES
 Our bodies are home to a multitude of microbial or-
ganisms that form distinct microflora inhabiting the gut, skin, 
vagina and oral cavity. These microbial communities have been 
of great interest to scientists in recent years due to their impact 
on host health and disease. Increasing lines of evidence indicate 
that these commensal microbiotas have important metabolic, 
trophic, and protective functions and greatly affect the host’s 
physiology and pathology.8,9 For example, the importance of the 
gut flora in digesting unutilized substrates, training the immune 
system and protecting against epithelial cell injury is well appre-
ciated,10-12 and we are beginning to understand its potential role 
in systemic diseases, such as inflammatory bowel disease13,14 and 
obesity.15
 Molecular biological tools have been critically impor-
tant for identifying the diversity of these host-associated micro-
biotas, including the oral microbial community.16 Prior to the 
availability of such tools, determining the diversity of complex 
microbiological communities, such as those of the oral micro-
biota had been essentially dependent on the ability to culture 
and identify individual organisms.  However, we then realized 
that only a small fraction of the organisms comprising these 
microbial communities has been isolated.6 In fact, accumulat-
ing lines of evidence suggested that there are extensive physical 
and metabolic interactions between different microbial species 
within the same community, which are essential for the growth 
and persistence of certain microbes17 and make them recalcitrant 
to cultivation.  The power of molecular biological approaches, 
such as culture-independent 16S rRNA gene sequencing-based 
methods allows us to identify yet-uncultivable species and pro-
vides a more comprehensive and detailed inventory of human 
oral microbiota.6 
 The studies using culture-independent approaches have 
revealed the sheer magnitude of the diverse microbes, includ-
ing yet-uncultivable species residing within the oral cavity.18,19 
The human mouth is estimated to harbor more than 700 differ-
ent bacterial species, comprising one of the most complex mi-
crobial flora.18  The diversity of microorganisms that inhabit the 
oral cavity includes bacteria, archaea, protozoa and fungi.20,21 
An interesting perspective regarding diversity of the oral flora 
is the presence of Archaea as a constituent.22  Phylogenetically, 
Archaea is among the oldest known type of prokaryotes; it has 
previously been isolated from ocean bottom, and yet also ap-
pears to be a colonizer of the human oral cavity with yet-to-be-
determined role in oral microbial ecology.23 The diversity of the 
microbial flora reflects tremendous genetic information and im-
mense bio-physiological potential that may have huge impact on 
host health and disease. If we consider that an average bacterial 
species has 2,000-6,000 genes, then an oral bacterial population 
of some 700 individual species represents a pool of over 1 mil-
lion genes, 10 times more than human host genes.  This provides 
the oral microbial environment with a huge quantity of informa-
tion related to unique metabolic pathways, the generation and 
secretion of various factors that can control and modify their 
ecological niche, and factors that may impact function of the 
human host.
 
THE STRUCTURE OF DENTAL AND DENTURE PLAQUE 
 Bacteria in the oral cavity often reside within biofilms, 
such as those that form dental and gingival plaque.24 For eden-
tulous and partially edentulous individuals who wear dentures, a 
denture-associated biofilm, or denture plaque, forms on the den-
ture surface and could potentially serve as a reservoir of patho-
genic microbes for infections.7  
 Dental and denture plaque are not simple matrices. 
They consist of a diverse collection of microbial species, and 
furthermore have a highly organized structure in which different 
species can occupy specific sites or niches within the biofilms.25 
During dental biofilm formation, bacteria that are early coloniz-
ers, such as Streptococci (i.e., S. gordonii, S. oralis, etc.) with 
specific adhesins can effectively bind to proteins deposited as a 
pellicle coat on the tooth surface.  This is followed by the sub-
sequent recruitment of intermediate and late colonizing species 
through cell-cell coadhesion via specific adhesin-receptor inter-
actions.25 These specific bacterial physical associations eventu-
ally generate a highly structured microbial community, which 
we recognize as dental plaque or biofilms.5,6,26 Furthermore, bac-
terial species within dental biofilm are often engaged in exten-
sive signaling and metabolic interactions to ensure their survival 
within the microbial community.6
 Dental biofilms of healthy subjects harbor a commensal 
oral microbial community with properties that limit the invasive 
potential of opportunistic pathogens.3,27 And likemost ecological 
communities, once established, dental biofilm generally has a 
stable and controlled population of different organisms and dis-
plays resilience to environmental disturbance.28,29  However, as 
will be discussed in the following section, the microbial com-
position of denture biofilm flora and their pathogenic potentials 
could differ significantly from that of healthy dental biofilm, 
thus contributing to the pathogenesis of denture-biofilm related 
diseases, such as stomatitis. 
CONNECTIONS BETWEEN MICROBES AND ORAL DISEASES 
ASSOCIATED WITH DENTURE WEARING
 Denture stomatitis is a common disorder in subjects 
wearing dentures, which are prostheses that provide important 
functional and esthetic improvements for edentulous and par-
tially edentulous patients.30,31 The disorder is characterized as 
inflammation and erythema of the oral mucosal areas covered 
by the denture.  The current view regarding the etiology of den-
ture stomatitis is that it is a multifactorial infectious disease. 
It involves a number of associative factors, including denture-
induced trauma, continual denture wearing and denture plaque 
harboring pathogenic microbes, such as Candida.30 Among those 






factors, the microbial biofilm formed on the denture surface 
plays a significant role in contributing to the disease pathogenic 
process. Whereas the normal commensal oral microbial com-
munity could prevent infection by interfering with the invasive 
potential of opportunistic pathogens, this is altered in the denture 
biofilm.  Indeed, the microbial composition of the biofilm which 
forms on denture surfaces differs significantly from that ob-
served in the oral cavity of healthy individuals.32,33 This could be 
due to the fact that denture wearing can alter normal oral physi-
ology by affecting normal salivary flow that plays an important 
role in shaping the microbial community.34 Meanwhile, the older 
segment of the population often has a comparable higher pro-
portion of denture wearer.35 These individuals are more likely 
to have systemic health conditions and could have already had 
imbalanced oral microbial ecosystem due to disturbance in host 
homeostasis. Furthermore, a denture provides a unique abiotic 
surface for microbial colonization, which often leads to the de-
velopment of a denture biofilm with microbial composition and 
structure different from normal oral biofilm.7,32
 Compared to the normal oral and dental biofilms, den-
ture biofilmsare associated with a much higher occurrence of 
Candida yeasts, particularly Candida albicans.36 C. albicans is a 
commensal fungal species commonly colonizing human muco-
sal surfaces. It co-exists with diverse oral microbial species and 
has long been adapted to the human host.37 In healthy individu-
als, C. albicans is usually a minor component of their oral mi-
crofloras. However, under conditions of immune dysfunction or 
local predisposing factors such as poor oral hygiene or ill-fitted 
dentures, colonizing C. albicans can become an opportunistic 
pathogen. In these patients, C. albicans becomes more predomi-
nant and invasive, causing recurrent mucosal infections such as 
denture stomatitis.38 The presence of C. albicans on denture and 
oral mucosal surfaces of denture wearers is positively associated 
with denture stomatitis.39 The virulence factors of C. albicans 
have been well documented.40 Among them, multiple host rec-
ognition biomolecules, such as Als1p and Hwp1p,41,42 as well 
as the secreted enzymes, including Aspartyl proteinases (SAP)43 
and Phospholipase (PL)44 have been shown to play important 
role in determining C. albicans’ pathogenicity. Meanwhile, its 
polymorphic growth patterns40 as well as phenotypic switching45 
have also been implicated in contributing to its virulence. While 
C. albicans infection cannot be claimed as the single causal 
pathogen for inducing denture stomatitis, it has a strong associa-
tive presence when the disorder occurs, and its eradication from 
denture and mucosal surfaces is associated with reversal of the 
condition.46,47 Hence, it is generally accepted that C. albicans is 
a main opportunistic pathogen which is involved in the develop-
ment and pathogenesis of denture stomatitis. Meanwhile, cer-
tain bacterial species, such as Prevotellasp., Veillonellasp. and 
Staphylococcus sp. have been found to be enriched in denture 
biofilms,48,49 although their potential role in denture stomatitis 
pathogenesis remains to be determined. More importantly, in-
creasing lines of evidence indicate the extensive Candida-bac-
terial interactions, which could impact their pathogenicity.37 For 
example, co-infection of C. albicans and Staphylococcus aureus 
has been shown to lead to increased mortality in animal model.50 
A better understanding of the physiology of Candida and bacte-
ria co-existence and the inter-kingdom Candida-bacterial inter-
actions would shed light on the impact of polymicrobial infec-
tion on the etiology of denture-related stomatitis. 
 
TREATMENT OF DENTURE-RELATED INFECTIOUS DISEASE
 Plaque formed on the denture surface often serves as a 
reservoir of opportunistic pathogens, including C. albicans for 
infections. In addition to maintaining good general oral hygiene, 
the most recommended approach to managing and preventing 
microbial-related disease associated with denture use is for pa-
tients to maintain a high level of denture hygiene by appropriate 
cleaning.51,52 Common approaches to denture cleaning utilized 
by patients include brushing with abrasive cleansers, such as 
toothpastes, and washing or soaking dentures using commercial 
chemical cleansers with antimicrobial compounds designed for 
this purpose. The latter is preferred, as brushing with abrasive 
cleansers has been shown to be less effective for removal of the 
biofilm, and furthermore, can roughen the denture surfaces and 
result in more rapid bacterial adherence and biofilm growth.7,53 
However, as observed with other biofilms, a problematic issue 
associated with denture plaque is that it reduces the effective-
ness of antimicrobial, including antifungal treatment.54 The 
mechanisms by which biofilm environments enhance antimi-
crobial resistance are not fully understood. However, putative 
mechanisms likely include decreased ability of the antimicrobial 
agents to penetrate and diffuse within the biofilm matrix, pro-
tective functions conferred to the putatively susceptible bacteria 
due to slower growth rates and even changes in phenotype, and 
perhaps protective factors secreted by other microbes within the 
biofilm community which can degrade the applied antimicro-
bial agents.55 In addition, the materials used in the manufacture 
of dentures can also affect adherence and colonization by mi-
crobes, including C. albicans, as well as impact the efficacy of 
antimicrobial treatment on thebiofilm.56  
 Soaking dentures in an appropriate commercial cleans-
er has been shown to be effective in removing attached microbes 
without increasing surface roughness.57 Overnight denture re-
moval is also important for controlling denture plaque, as it iso-
lates the denture from salivary secretion that provides nutrients 
for microbial growth of denture biofilm. In addition to main-
taining denture hygiene, various antimicrobials, including im-
idazole (clotrimazole, ketaconazole), triazole (fluconazole, itra-
conazole) and polyene (nystatin, amphotericin B) antifungals for 
treating Candida, and antibiotics for treating bacterial pathogens 
were also recommended for controlling denture-related mucosal 
infections.58,59 
 More recently, a new antifungal therapeutic approach 
Photodynamic (PDT) therapy has been used to treat denture sto-
matitis.60 PDT uses a photosensitizing agent and light of appro-





priate wavelength. The interaction between the photosensitizer 
and light in the presence of oxygen produces reactive species 
that induce cell damage and death.61 In a recent clinical trial, 
PDT was shown to be as effective as topical nystatin in the 
treatment of denture stomatitis.62 Since PDT can effectively kill 
Candida species, including strains resistant to conventional an-
tifungal agents,63 it has been regarded as a promising method 
for the treatment of dental stomatitis. Recurrence of stomatitis 
is frequently observed within short period of time after stop-
ping antifungal treatment.64  This is likely due to reinfection by 
residual pathogens that remain within plaque on dentures and 
are resistant to treatment. Meanwhile, many patients failed to 
respond to the usual treatment, largely due to the development 
of drug resistance of candida species. For patients with systemic 
diseases, such as type 2 diabetes mellitus or being immunocom-
promised,65 they often show less responsiveness to the treatment 
as well. When treating these patients, combined efforts including 
antifungal treatment and improving patients overall health status 
are critical in determining the outcome.66
 The knowledge we are gaining from molecular biologi-
cal studies of dental and denture biofilms is contributing to the 
development of novel therapeutic tools.6,67 One approach is to 
build on our ability to identify specific pathogenic organisms 
that inhabit the biofilm, and develop therapeutics that specifi-
cally target these organisms. An example of this approach un-
dertaken by our research group is the development of STAMPs 
(Specifically Targeted Antimicrobial Peptides).68,69 A typical 
STAMP consists of two functional moieties conjoined in a linear 
peptide sequence: a nonspecific antimicrobial peptide serves as 
the killing moiety, whereas a species-specific binding peptide 
provides specific binding to a selected pathogen and facilitates 
the targeted delivery of the attached antimicrobial peptide. The 
feasibility of this approach has been demonstrated by the devel-
opment of C16G2, a STAMP specifically targeting S.mutans, the 
bacterium known to cause dental caries.  C16G2 has been shown 
to remove S. mutans within in vitro multi-species biofilms with 
high efficacy and specificity,68,70 and is under further animal and 
human evaluations.71 The successful demonstration of this tar-
geted approach could serve as proof-of-concept for applying this 




 The past decade has witnessed significant advances in 
our understanding of oral microbiota.  We now better understand 
the structural and functional complexity of dental and denture 
plaque, and a strong connection between oral microbial ecol-
ogy and host health and disease has been established. It is well 
known that the control of microbial pathogens, such C. albicans 
on dentures and in the oral cavity is critical for the oral health 
of denture wearers. Continued efforts using modern scientific 
methods will help us develop more diagnostic tools and thera-
peutic interventions for the identification, treatment and preven-
tion of denture infections. New and improved approaches will 
be able to treat and control denture infections with less physical 
damage to denture surfaces by providing improved mechanisms 
for killing and removing microorganisms in the denture biofilm. 
We can envisage products that will have targeted killing of se-
lective pathogens without affecting other commensal species 
within the same denture biofilm. Finally, we can also expect to 
see new products that will be able to enhance natural oral immu-
nity, and provide cavity protection or control gingival disease in 
dentate individuals, and other inflammatory disorders in denture 
wearers.  
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